Chemotherapeutic potential of radotinib against blood and solid tumors: A beacon of hope in drug repurposing.
Parkinson's Disease Literature
Publication date: Dec 07, 2024 Tyrosine kinase inhibitors (TKIs) represent a pivotal class of targeted therapies in oncology, with multiple generations developed to address diverse molecular targets. Imatinib is the ... Read more